RAFAEL
RODRIGUEZ PUERTAS
INVESTIGADOR/A DOCTOR/A PERMANENTE
Publicaciones (70) Publicaciones de RAFAEL RODRIGUEZ PUERTAS
2024
-
Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers
Vaccine, Vol. 42, Núm. 18, pp. 3916-3929
-
Frontal Cortex Lipid Alterations During the Onset of Alzheimer’s Disease
Journal of Alzheimer's Disease, Vol. 98, Núm. 4, pp. 1515-1532
-
Neurolipid systems: A new target for the treatment of dementia
Basic and Clinical Pharmacology and Toxicology, Vol. 135, Núm. 3, pp. 225-236
2023
-
Cannabinoids and endocannabinoid signaling at the basal forebrain cholinergic system
Cannabis Use, Neurobiology, Psychology, and Treatment (Elsevier), pp. 417-430
-
Mass Spectrometry for the Advancement of Lipid Analysis in Alzheimer’s Research
Methods in Molecular Biology (Humana Press Inc.), pp. 245-259
-
Microarrays, Enzymatic Assays, and MALDI-MS for Determining Specific Alterations to Mitochondrial Electron Transport Chain Activity, ROS Formation, and Lipid Composition in a Monkey Model of Parkinson’s Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 6
-
Neuroanatomical characterization of the G protein-coupled receptor activity evoked by galanin-related ligands
Journal of Chemical Neuroanatomy, Vol. 128
2022
-
Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion
ACS Pharmacology and Translational Science, Vol. 5, Núm. 9, pp. 791-802
-
Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome
eLife, Vol. 11
-
Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis
European Journal of Neuroscience, Vol. 55, Núm. 6, pp. 1532-1546
2021
-
Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108
-
Modulation of neurolipid signaling and specific lipid species in the triple transgenic mouse model of alzheimer’s disease
International Journal of Molecular Sciences, Vol. 22, Núm. 22
-
Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer’s disease
Journal of Neuroinflammation, Vol. 18, Núm. 1
-
Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease
ACS Chemical Neuroscience, Vol. 12, Núm. 12, pp. 2167-2181
2020
-
ACE2 activators for the treatment of COVID 19 patients
Journal of Medical Virology
-
Lisofosfolipidoen eta Alzheimer gaixotasunaren arteko erlazioa: etorkizuneko itu farmakologikoaren bila.
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 38, pp. 55-71
-
Neuropeptides and neurolipids: What they are and how they relate to Alzheimer’s disease
Genetics, Neurology, Behavior, and Diet in Dementia: The Neuroscience of Dementia, Volume 2 (Elsevier), pp. 423-439
-
Neurotransmitter receptors in Alzheimer’s disease: From glutamatergic to cholinergic receptors
Genetics, Neurology, Behavior, and Diet in Dementia: The Neuroscience of Dementia, Volume 2 (Elsevier), pp. 441-456
-
Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats
Frontiers in Cellular Neuroscience, Vol. 14
2019
-
CB1 and LPA1 Receptors Relationship in the Mouse Central Nervous System
Frontiers in Molecular Neuroscience, Vol. 12